AdAlta Bridges East-West Divide to Propel Biotech Innovation
1 Articles
1 Articles
AdAlta Bridges East-West Divide to Propel Biotech Innovation
Posted: 23rd April 2025 AdAlta launched AdCella, a new subsidiary to bring advanced cellular immunotherapies from China to Western markets. This initiative was supported by SYNthesis BioVentures Fund (SYNBV), which saw great potential in AdCella’s strategy amid US-China… The post AdAlta Bridges East-West Divide to Propel Biotech Innovation first appeared on BioMelbourne Network.
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage